AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Advancements in Detecting MRD in Myeloma and FDA Meeting Insights
The chapter explores innovative techniques like next generation flow and sequencing for detecting minimal residual disease in myeloma, referencing the FDA meeting discussing MRD as an endpoint and the panel's endorsement for surrogate endpoint use in accelerated approval.